[Retracted] Efficacy and Safety of Intravitreal Injection of Triamcinolone Acetonide and Conbercept for Intraocular Lens after Cataract Surgery

Table 5

Comparison of incidence rate of postoperative complications (n (%)).

Item	Conbercept group (n = 176)	Triamcinolone acetonide group (n = 174)	Χ2	value
Conjunctival hyperemia (mild/moderate/severe, cases)	68/20/0	79/25/0	0.046	0.813
Eye phobia (case (%))	19 (0.11)	18 (0.10)	0.019	0.981
Eyes with lacrimation (case (%))	16 (0.09)	14 (0.08)	0.122	0.727
Foreign body sensation in eyes (case (%))	14 (0.08)	16 (0.09)	0.172	0.678
Eye pain (case (%))	16 (0.09)	28 (0.16)	3.902	0.048
Corneal edema (case (%))	17 (0.10)	11 (0.06)	1.324	0.250
Posterior subcapsular opacification (case (%))	16 (0.09)	23 (0.13)	1.505	0.220
Intraocular pressure increased (case (%))	10 (0.06)	77 (0.44)	69.691	<0.001
Eye swelling (case (%))	23 (0.13)	56 (0.32)	18.294	<0.001
Orbital pain (case (%))	12 (0.07)	25 (0.14)	5.275	0.022
Headache and vomiting (case (%))	14 (0.08)	26 (0.15)	4.221	0.040